210 related articles for article (PubMed ID: 35138228)
1. An initial exploration of the convergent and ecological validity of the UDS 3.0 neuropsychological battery in Parkinson's Disease.
Lea R; Benge JF; Adler CH; Beach TG; Belden CM; Zhang N; Shill HA; Driver-Dunckley E; Mehta SH; Atri A
J Clin Exp Neuropsychol; 2021 Nov; 43(9):918-925. PubMed ID: 35138228
[TBL] [Abstract][Full Text] [Related]
2. The ecological validity of the Uniform Data Set 3.0 neuropsychological battery in individuals with mild cognitive impairment and dementia.
Benge JF; Artz JD; Kiselica AM
Clin Neuropsychol; 2022 Aug; 36(6):1453-1470. PubMed ID: 33103615
[No Abstract] [Full Text] [Related]
3. A time-efficient screening tool for activities of daily living functions in Parkinson's disease dementia.
Sulzer P; Liebig L; Csoti I; Graessel E; Wurster I; Berg D; Liepelt-Scarfone I
J Clin Exp Neuropsychol; 2020 Oct; 42(8):867-879. PubMed ID: 33043797
[TBL] [Abstract][Full Text] [Related]
4. Quantifying activities of daily living impairment in Parkinson's disease using the Functional Activities Questionnaire.
Becker S; Pauly C; Lawton M; Hipp G; Bowring F; Sulzer P; Hu M; Krüger R; Gasser T; Liepelt-Scarfone I
Neurol Sci; 2022 Feb; 43(2):1047-1054. PubMed ID: 34109514
[TBL] [Abstract][Full Text] [Related]
5. Assessment of Cognitive-Driven Performance-Based Activities of Daily Living Dysfunction in Parkinson's Disease.
Sulzer P; Bäumer A; Hoang HG; Becker S; Lönneker HD; Graessel E; Liepelt-Scarfone I
J Int Neuropsychol Soc; 2020 Apr; 26(4):430-440. PubMed ID: 31822319
[TBL] [Abstract][Full Text] [Related]
6. Association of cognitive activities of daily living (ADL) function and nonmotor burden in nondemented Parkinson's disease patients.
Becker S; Bäumer A; Maetzler W; Nussbaum S; Tkaczynska Z; Sulzer P; Timmers M; Van Nueten L; Salvadore G; Brockmann K; Streffer J; Berg D; Liepelt-Scarfone I
Neuropsychology; 2020 May; 34(4):447-455. PubMed ID: 32191056
[TBL] [Abstract][Full Text] [Related]
7. Assessment of cognitive-driven activity of daily living impairment in non-demented Parkinson's patients.
Becker S; Bäumer A; Maetzler W; Nussbaum S; Timmers M; Van Nueten L; Salvadore G; Zaunbrecher D; Roeben B; Brockmann K; Streffer J; Berg D; Liepelt-Scarfone I
J Neuropsychol; 2020 Mar; 14(1):69-84. PubMed ID: 30320954
[TBL] [Abstract][Full Text] [Related]
8. Psychometric Properties of the Clinical Dementia Rating Scale Sum of Boxes in Parkinson's Disease.
Gallagher J; Rick J; Xie SX; Martinez-Martin P; Mamikonyan E; Chen-Plotkin A; Dahodwala N; Morley J; Duda JE; Trojanowski JQ; Siderowf A; Weintraub D
J Parkinsons Dis; 2021; 11(2):737-745. PubMed ID: 33386814
[TBL] [Abstract][Full Text] [Related]
9. Smartphone-Based Neuropsychological Assessment in Parkinson's Disease: Feasibility, Validity, and Contextually Driven Variability in Cognition.
Weizenbaum EL; Fulford D; Torous J; Pinsky E; Kolachalama VB; Cronin-Golomb A
J Int Neuropsychol Soc; 2022 Apr; 28(4):401-413. PubMed ID: 33998438
[TBL] [Abstract][Full Text] [Related]
10. A new device-aided cognitive function test, User eXperience-Trail Making Test (UX-TMT), sensitively detects neuropsychological performance in patients with dementia and Parkinson's disease.
Kokubo N; Yokoi Y; Saitoh Y; Murata M; Maruo K; Takebayashi Y; Shinmei I; Yoshimoto S; Horikoshi M
BMC Psychiatry; 2018 Jul; 18(1):220. PubMed ID: 29976167
[TBL] [Abstract][Full Text] [Related]
11. Responsiveness to Change of the Montreal Cognitive Assessment, Mini-Mental State Examination, and SCOPA-Cog in Non-Demented Patients with Parkinson's Disease.
Faust-Socher A; Duff-Canning S; Grabovsky A; Armstrong MJ; Rothberg B; Eslinger PJ; Meaney CA; Schneider RB; Tang-Wai DF; Fox SH; Zadikoff C; Kennedy N; Chou KL; Persad C; Litvan I; Mast BT; Gerstenecker AT; Weintraub S; Reginold W; Marras C
Dement Geriatr Cogn Disord; 2019; 47(4-6):187-197. PubMed ID: 31315127
[TBL] [Abstract][Full Text] [Related]
12. Reliability, validity, and diagnostic accuracy of Parkinson's Disease-Cognitive Rating Scale in Iranian patients with idiopathic Parkinson's disease.
Mahmoudi Asl A; Mehdizadeh M; Kulisevsky J; Sabet A; Taghavi Azar Sharabiani P; Mehdizadeh H; Ashayeri H; Taghizadeh G
Disabil Rehabil; 2022 May; 44(10):2091-2098. PubMed ID: 32924645
[TBL] [Abstract][Full Text] [Related]
13. Beyond PD-MCI: objectively defined subtle cognitive decline predicts future cognitive and functional changes.
Jones JD; Uribe C; Bunch J; Thomas KR
J Neurol; 2021 Jan; 268(1):337-345. PubMed ID: 32804281
[TBL] [Abstract][Full Text] [Related]
14. Instrumental activities of daily living are impaired in Parkinson's disease patients with mild cognitive impairment.
Pirogovsky E; Schiehser DM; Obtera KM; Burke MM; Lessig SL; Song DD; Litvan I; Filoteo JV
Neuropsychology; 2014 Mar; 28(2):229-37. PubMed ID: 24417192
[TBL] [Abstract][Full Text] [Related]
15. Mild cognitive impairment in Parkinson's disease versus Alzheimer's disease.
Besser LM; Litvan I; Monsell SE; Mock C; Weintraub S; Zhou XH; Kukull W
Parkinsonism Relat Disord; 2016 Jun; 27():54-60. PubMed ID: 27089852
[TBL] [Abstract][Full Text] [Related]
16. Rapid communication: Preliminary validation of a telephone adapted Montreal Cognitive Assessment for the identification of mild cognitive impairment in Parkinson's disease.
Benge JF; Kiselica AM
Clin Neuropsychol; 2021 Jan; 35(1):133-147. PubMed ID: 32779959
[No Abstract] [Full Text] [Related]
17. A Comparison of Functional Abilities in Individuals with Mild Cognitive Impairment and Parkinson's Disease with Mild Cognitive Impairment Using Multiple Assessment Methods.
Schmitter-Edgecombe M; McAlister C; Greeley D
J Int Neuropsychol Soc; 2022 Sep; 28(8):798-809. PubMed ID: 34486508
[TBL] [Abstract][Full Text] [Related]
18. An assessment of Movement Disorder Society Task Force diagnostic criteria for mild cognitive impairment in Parkinson's disease.
Uysal-Cantürk P; Hanağası HA; Bilgiç B; Gürvit H; Emre M
Eur J Neurol; 2018 Jan; 25(1):148-153. PubMed ID: 28941002
[TBL] [Abstract][Full Text] [Related]
19. Parkinson's Disease--Cognitive Functional Rating Scale across different conditions and degrees of cognitive impairment.
Ruzafa-Valiente E; Fernández-Bobadilla R; García-Sánchez C; Pagonabarraga J; Martínez-Horta S; Kulisevsky J
J Neurol Sci; 2016 Feb; 361():66-71. PubMed ID: 26810519
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic and screening power of neuropsychological testing in detecting mild cognitive impairment in Parkinson's disease.
Biundo R; Weis L; Pilleri M; Facchini S; Formento-Dojot P; Vallelunga A; Antonini A
J Neural Transm (Vienna); 2013 Apr; 120(4):627-33. PubMed ID: 23483334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
